-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Initiates Coverage On Cellectis with Overweight Rating, Announces Price Target of $9

Benzinga·05/28/2026 13:37:08
Listen to the news
Barclays analyst Lukas Shumway initiates coverage on Cellectis (NASDAQ:CLLS) with a Overweight rating and announces Price Target of $9.